At CooperVision, we are committed to bringing the latest technology to you and your patients. CooperVision is discontinuing Biomedics® toric trials on May 1, 2025, and revenue packs on May 1, 2026, in order to simplify our product line and allow you to focus on fitting your patients in more innovative products.
A healthy* lens wearing experience
Your patients look to you to recommend the best option for their eyes.†‡ Take advantage of newer technologies and consider upgrading your patients to clariti® 1 day toric or Biofinity® toric monthly replacement lenses. In doing so, you will benefit from:
• Maximizing patient satisfaction§1,2
• Management of contact lens drop out3-5
• Saving your patients money with high-value patient rebates◊
Avaira Vitality® toric is another option if you’d prefer to keep your patients in the 2-week modality.
Please contact your CooperVision Sales Representative or our Customer Service team at 800 341 2020 if you have any questions about these products, rebates, or refitting patients.
Product Details
(0.50D steps after -6.00D and +5.00D)
(10° steps)
*With high oxygen delivery for daily wear, SiHy materials minimize or eliminate hypoxia-related complications.
†Defined as made from a material that provides 100% of the oxygen my eyes need.
‡CVI data on file 2019. Online YouGov Plc survey (conducted 2018). N=1520 adult CL wearers in US, UK and Japan.
§On average, 85% strongly/somewhat agree.
◊Pricing is based on manufacturer’s published MSRP and rebates as of 11/2024.
CVI data on file, 2020. Kubic masked online survey; n=224 US ODs who prescribe clariti 1 day toric. Top 3 boxes, strongly agree, agree, slightly agree.
CVI data on file 2021. Decision Analyst online survey of 376 Biofinity prescribing ECPs in USA, Japan, Germany, France and Spain.
Pucker, A. A Review of Contact Lens Dropout; Clinical Optometry 2020:12 85–94.
CVI data on file, 2013. MR online survey of Biofinity® sphere, toric and multifocal wearers in US, Germany & France; n=336.
CVI data on file, 2024.
